RIDGEBACK CAPITAL
Ridgeback Capital is a private investment firm that focuses on private and public companies in the life sciences sector. The company was founded in 2006 by Dr. Holman and is headquartered in New York, NY.
RIDGEBACK CAPITAL
Industry:
Biotechnology Finance Financial Services
Founded:
2006-01-01
Status:
Active
Contact:
212-624-2600
Technology used in webpage:
Viewport Meta SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Euro Organization Schema Person Schema COVID-19
Similar Organizations
Casdin Capital
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Leo Sternlicht Director @ Ridgeback Capital
Director
2010-10-01
Wayne Holman CEO @ Ridgeback Capital
CEO
2006-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-02 | Crisp | Ridgeback Capital investment in Series B - Crisp | 35 M USD |
| 2021-12-07 | Freenome | Ridgeback Capital investment in Series D - Freenome | 300 M USD |
| 2021-11-29 | Quell Therapeutics | Ridgeback Capital investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-11-09 | Arbor Biotechnologies | Ridgeback Capital investment in Series B - Arbor Biotechnologies | 215 M USD |
| 2021-09-23 | Garuda Therapeutics | Ridgeback Capital investment in Series A - Garuda Therapeutics | 72 M USD |
| 2021-07-14 | Turnstone Biologics | Ridgeback Capital investment in Series D - Turnstone Biologics | 80 M USD |
| 2021-05-06 | TwinStrand Biosciences | Ridgeback Capital investment in Series B - TwinStrand Biosciences | 50 M USD |
| 2021-03-30 | Pyxis Oncology | Ridgeback Capital investment in Series B - Pyxis Oncology | 152 M USD |
| 2021-03-16 | Acepodia | Ridgeback Capital investment in Series B - Acepodia | 47 M USD |
| 2021-03-03 | Caribou Biosciences | Ridgeback Capital investment in Series C - Caribou Biosciences | 115 M USD |
More informations about "Ridgeback Capital"
Ridgeback Capital Management
Ridgeback Capital is an actively managed private investment company that specializes in both securities trading and long-term private investment, with a specialized focus on investing in life …See details»
Meet Our Team — Ridgeback Capital Management
Ridgeback Capital was founded in 2006 and is focused on healthcare investments. Ridgeback invests in private and public companies that are dedicated to the development of life saving …See details»
Ridgeback Capital Management - LinkedIn
Biotech, pharmaceuticals, drug development, venture capital, computational drug discovery, machine learning, small molecules, and gene editing Locations PrimarySee details»
Wayne Holman, MD - Ridgeback Capital Management
Dr. Wayne Holman, Founder and CEO of Ridgeback Capital, co-founder of Ridgeback Biotherapeutics, and Co-Chair of the Ridgeback-Merck Molnupiravir Joint Steering Committee, has dedicated over two decades to funding more …See details»
Wayne Holman - CEO @ Ridgeback Capital - Crunchbase
Wayne Holman is the Founder and CEO of Ridgeback Capital, and Co-Chair of the Ridgeback-Merck Molnupiravir Joint Steering Committee. He is also the co-founder of Ridgeback Biotherapeutics, the biotechnology company that he …See details»
Ridgeback Capital Investor Profile: Portfolio & Exits
Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Ridgeback Capital. Use the PitchBook Platform to explore the full profile.See details»
Ridgeback Capital Management LP - Company Profile and News
Company profile page for Ridgeback Capital Management LP including stock price, company news, executives, board members, and contact informationSee details»
Ridgeback Capital Management - CB Insights
Dec 7, 2021 · Ridgeback Capital Management has made 31 investments. Their latest investment was in LENZ Therapeutics as part of their PIPE on July 14, 2024. New? Ridgeback Capital …See details»
Track Record – Ridgeback
The executive team at Ridgeback has extensive energy experience and has worked together successfully at prior private equity-backed companies. CanEra Resources Inc. (CanEra I) Incorporated in 2008 with $350mm in initial …See details»
LENZ Therapeutics Announces $30 Million Investment from …
Jul 15, 2024 · This can benefit millions of people who live with the challenges of presbyopia, and we are excited to support the LENZ team in this effort,” said Dr. Wayne Holman, Chief …See details»
Understanding Ridgeback: The Inspiration Behind Our Name
Aug 30, 2022 · At Ridgeback Capital Management, we consider it an honor to share our experience with each of our mountain climbers, knowing there is a sense of trust and …See details»
Ridgeback Capital Management - Crunchbase
Ridgeback Capital Management offers investment allocation, tax reduction planning, retirement planning, and family wealth planning services.See details»
news — Ridgeback Capital Management
Ridgeback Capital, founded by Wayne Holman, joins investment in Arbor Biotechnologies Series B Financing to Advance Next-Generation Precision Editing Therapeutics – 11.9.2021. Globe …See details»
Ridgeback Capital - Recent News & Activity - Crunchbase
Ridgeback Capital is a private investment company that is focused on investing in life science companies.See details»
Jeffrey Long-McGie - Managing Director / Analyst …
Managing Director at Ridgeback Capital · Jeffrey views himself as a modern day renaissance man. He believes in working hard, and his ability to learn anything.See details»
RIDGEBACK CAPITAL INVESTMENTS L.P. - WhaleWisdom.com
Sep 30, 2024 · Detailed Profile of RIDGEBACK CAPITAL INVESTMENTS L.P. portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.See details»
Ridgeback Resources Corporate Presentation
One of the largest credit-oriented alternative asset managers in the world with assets under management of US$139 billion.See details»
Select Investments - Ridgeback Capital Management
Info@ridgebackcap.com | 212-624-2600. 348 West 14th Street, New York, NY, 10014See details»
Saturn Oil & Gas Inc. Announces Acquisition of Ridgeback
Jan 20, 2023 · Through the Ridgeback Acquisition, Saturn will acquire approximately 17,000 boe/d (~71% light oil and natural gas liquids (" NGLs ")) 6 of low decline, capital efficient …See details»
Saturn Oil & Gas Inc. Announces Closing of the Acquisition of …
Feb 28, 2023 · The assets acquired from Ridgeback benefit from responsibly deployed capital directed to abandonment and reclamation programs with limited inactive liabilities and a strong …See details»